Literature DB >> 12715887

Hepatitis B virus core antigen: enhancement of its production in Escherichia coli, and interaction of the core particles with the viral surface antigen.

Wen Siang Tan1, Michael R Dyson, Kenneth Murray.   

Abstract

The core antigen (HBcAg) of hepatitis B Virus (HBV) can be expressed in Escherichia coil where it assembles into icosahedral particles containing 240 or 180 subunits. Analysis of the two kinds of particles by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) showed that a substantial proportion of their subunits were smaller than the full-length HBcAg monomer and of variable size, but all had the same N-terminal sequence showing that the smaller species were heterogeneous in their arginine-rich C-terminal regions. Around 50% of these arginine residues are encoded by the triplet AGA which is rare in E. coli. Supplementation of the level of AGA tRNA in the cell by transformation with plasmids expressing the T4 AGA tRNA gene significantly enhanced the yield of HBcAg. Fusion phage carrying a ligand specific for HBcAg showed no significant difference in the affinity for the two sizes of HBcAg particles, but in similar reactions in solution HBV surface antigen exhibited differential affinities for the same two HBcAg preparations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12715887     DOI: 10.1515/BC.2003.042

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  13 in total

1.  Mining mammalian genomes for folding competent proteins using Tat-dependent genetic selection in Escherichia coli.

Authors:  Hyung-Kwon Lim; Thomas J Mansell; Stephen W Linderman; Adam C Fisher; Michael R Dyson; Matthew P DeLisa
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

2.  Crystallization and X-ray analysis of the T = 4 particle of hepatitis B capsid protein with an N-terminal extension.

Authors:  Wen Siang Tan; Iain W McNae; Kok Lian Ho; Malcolm D Walkinshaw
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-21

3.  Production of soluble mammalian proteins in Escherichia coli: identification of protein features that correlate with successful expression.

Authors:  Michael R Dyson; S Paul Shadbolt; Karen J Vincent; Rajika L Perera; John McCafferty
Journal:  BMC Biotechnol       Date:  2004-12-14       Impact factor: 2.563

4.  pH-responsive Virus-like Nanoparticles with Enhanced Tumour-targeting Ligands for Cancer Drug Delivery.

Authors:  Roya Biabanikhankahdani; Noorjahan Banu Mohamed Alitheen; Kok Lian Ho; Wen Siang Tan
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

5.  A Simple Add-and-Display Method for Immobilisation of Cancer Drug on His-tagged Virus-like Nanoparticles for Controlled Drug Delivery.

Authors:  Roya Biabanikhankahdani; Saadi Bayat; Kok Lian Ho; Noorjahan Banu Mohamed Alitheen; Wen Siang Tan
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

6.  Targeted Delivery of Cell Penetrating Peptide Virus-like Nanoparticles to Skin Cancer Cells.

Authors:  Bee Koon Gan; Chean Yeah Yong; Kok Lian Ho; Abdul Rahman Omar; Noorjahan Banu Alitheen; Wen Siang Tan
Journal:  Sci Rep       Date:  2018-05-31       Impact factor: 4.379

7.  A Dual Bioconjugated Virus-Like Nanoparticle as a Drug Delivery System and Comparison with a pH-Responsive Delivery System.

Authors:  Roya Biabanikhankahdani; Kok Lian Ho; Noorjahan Banu Alitheen; Wen Siang Tan
Journal:  Nanomaterials (Basel)       Date:  2018-04-13       Impact factor: 5.076

8.  Epitope selection and their placement for increased virus neutralization in a novel vaccination strategy for porcine epidemic diarrhea virus utilizing the Hepatitis B virus core antigen.

Authors:  Frank Gillam; Chenming Zhang
Journal:  Vaccine       Date:  2018-06-15       Impact factor: 3.641

9.  Solubility enhancement of aggregation-prone heterologous proteins by fusion expression using stress-responsive Escherichia coli protein, RpoS.

Authors:  Jin-Seung Park; Kyung-Yeon Han; Jong-Ho Lee; Jong-Am Song; Keum-Young Ahn; Hyuk-Seong Seo; Sang-Jun Jun Sim; Seung-Wook Kim; Jeewon Lee
Journal:  BMC Biotechnol       Date:  2008-02-19       Impact factor: 2.563

10.  Shielding of Hepatitis B Virus-Like Nanoparticle with Poly(2-Ethyl-2-Oxazoline).

Authors:  See Yee Fam; Chin Fei Chee; Chean Yeah Yong; Kok Lian Ho; Abdul Razak Mariatulqabtiah; Han Yih Lau; Wen Siang Tan
Journal:  Int J Mol Sci       Date:  2019-10-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.